“...pleasure and pain, they come and go and don't last... bear them patiently”
—Gita
Pathos InvestmentsEquity Research
Research  ›  Fact Sheets  ›  BG

BUNGE GLOBAL SA

LISTEDNYSE
SYMBOLBG
SIC2070
STATE OF INC.V8
FISCAL YEAR ENDSDecember 31
CIK1996862

FATS & OILS · LARGE ACCELERATED FILER · 5 FISCAL YEARS OF SEC XBRL DATA, 2021–2025

REVENUES, NET INCOME AND FREE CASH FLOW BY FISCAL YEAR$ billions-2002040608020212022202320242025RevenuesNet incomeFree cash flowEARNINGS AND DIVIDENDS PER SHARE$ per share0.005.0010.0015.0020212022202320242025EPS dilutedDividends per share

Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.

CAPITALIZATION 12/31/25

($ millions)Amount%
Total debt14,05146.9
Stockholders' equity15,90453.1
Total capitalization29,955100.0

194,018,115 shares outstanding at 27 April 2026 (cover page of the 10-Q filed 29 April 2026).

LONG-TERM DEBT 12/31/25

($ millions)Amount
Long-term debt, incl. current maturities10,168
Long-term debt, noncurrent8,831
Current maturities1,337
Short-term borrowings / commercial paper3,883

CAPITAL STOCK 12/31/25

Treasury shares15,103,107
Outstanding at 4/27/26194,018,115

DIVIDENDS DECLARED/PAID

Fiscal yearPer share $Payout %
20252.8057.0
20242.7234.0
20232.6117.6
20222.4022.8
20212.0815.2

HISTORY AND BUSINESS

HISTORY: Incorporated in Switzerland.

BUSINESS: Classified by the SEC under Standard Industrial Classification 2070, Fats & Oils. Large accelerated filer. Principal executive office: Route De Florissant 13, Geneva, V8 1206. Fiscal year ends December 31. For a description of the business, see Item 1 of the latest 10-K.

CONSOLIDATED INCOME ACCOUNT, YEARS ENDED

($ millions)12/31/2512/31/2412/31/23
Revenues16,94415,55017,831
Cost of revenues66,92049,71554,695
Gross profit3,4093,3934,845
Research and development283035
Selling, general and administrative2,1131,7761,715
Depreciation and amortization703468451
Interest expense628471516
Income before income taxes1,1341,5243,051
Income taxes288336714
Net income8161,1372,243
Earned per share, diluted ($)4.917.9914.87
Dividends per share ($)2.802.722.61

CONSOLIDATED BALANCE SHEET

($ millions)12/31/2512/31/24
Cash and equivalents1,1353,311
Receivables, net3,8702,148
Inventories13,1986,491
Total current assets24,39115,958
Property, plant and equipment, net11,6785,254
Goodwill3,141453
Total assets44,52824,899
Total current liabilities15,1277,435
Long-term debt8,8314,694
Stockholders' equity15,9049,913
Total liabilities and equity44,52824,899

TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)

Fiscal year endedRevenuesOper. incomeNet incomeNet margin %EPS diluted $Div. per share $Oper. cash flowCapital expend.Free cash flowTotal assetsTotal liabilitiesTotal debtStockholders' equityROE %Debt / equity
12/31/2570,329–8161.24.912.808441,723(879)44,52827,159d14,05115,9045.10.88
12/31/2453,108–1,1372.17.992.721,9001,37652424,89913,954d6,2389,91311.50.63
12/31/2359,540–2,2433.814.872.613,3081,1222,18625,37213,558d4,88210,85120.70.45
12/31/2267,232–1,6102.410.512.40(5,549)555(6,104)24,58014,624d4,6519,22417.50.50
12/31/2159,152–2,0783.513.642.08(2,894)399(3,293)23,81915,994d–7,82526.6–

Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.

REGISTRANT:

Bunge Global SA
CIK 1996862 · EIN 00-0000000

PRINCIPAL OFFICE:

Route De Florissant 13, Geneva, V8 1206
Tel.: 41 22 592 91 00

INCORPORATED:

Switzerland

INDUSTRY (SEC SIC CODE):

2070 · Fats & Oils

FILER STATUS:

Large accelerated filer

LATEST ANNUAL REPORT:

10-K for period ended 12/31/25, filed 19 February 2026

RECENT FILINGS (ANNUAL REPORT REFERENCES BELOW):

10/5/268-Kperiod 10/5/26
9/21/268-Kperiod 9/17/26
9/3/268-Kperiod 9/1/26
8/19/268-Kperiod 8/17/26
7/29/2610-Qperiod 6/30/26
7/29/268-Kperiod 7/29/26
5/22/268-Kperiod 5/20/26
4/29/2610-Qperiod 3/31/26

Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 2/19/26) · 10-K FY2024 (filed 2/20/25) · 10-K FY2023 (filed 2/22/24). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.

Data from SEC filings. © 2026 Pathos Investments · pathosinvestments.com · For educational purposes only. Not investment advice.

Data from SEC filings  ·  Educational only  ·  Not investment advice